Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

MoonLake Immunotherapeutics (MLTX) Return on Assets (2021 - 2026)

MoonLake Immunotherapeutics' Return on Assets history spans 6 years, with the latest figure at 0.01% for Q1 2026.

  • Quarterly Return on Assets changed 0.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Assets came in at 0.01% for Q1 2026, down from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2024 to a low of 0.01% in Q3 2022.
  • The 5-year median for Return on Assets is 0.0% (2025), against an average of 0.0%.
  • The largest YoY upside for Return on Assets was 1bps in 2022 against a maximum downside of -1bps in 2022.
  • MoonLake Immunotherapeutics' Return on Assets stood at 0.01% in 2022, then surged by 89bps to 0.0% in 2023, then crashed by -184bps to 0.0% in 2024, then plummeted by -126bps to 0.01% in 2025, then fell by -15bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Return on Assets are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025).